IME Medical Electrospinning, a Waalre, The Netherlands-based global leader in electrospun medical devices and regenerative medicine, raised €3m in equity and debt financing.
Backers included existing shareholder TIIN Capital, new investors Borski Fund and Lumana Invest, and Rabobank Region Eindhoven.
The company intends to use the funds to further strengthen its MediSpin XL electropinning platform and industrial production capabilities for medical devices and drug delivery applications.
Led by Managing Directors Ramon Solberg and Judith Heikoop, IME Medical Electrospinning, Medical Electrospinning applies specific polymers to create fiber-based medical device solutions that mimic the natural human extracellular matrix in nanometer and micrometer format for implants and membranes in the human body. Human cells recognize this artificial matrix (scaffold) as the body’s own facilitating the repair of the damaged tissue for heart valves, blood vessels, nerves, tendons, skin and bone etc. The MediSpin™ XL platform has been developed specifically for MedTech industrial manufacturing of medical devices and is now also suitable for pharmaceutical drug delivery applicaitons and ensures the firm control of the crucial parameters of the electrospinning process, leading to identical and consistent end-products.
Customers and scientific partners include the MedTech and Pharma industry, scientists and health institutions.